Table 1 |
||||
|
Correlations between TLR4 expression and clinicopathologic variables of HCC. |
||||
|
Clinicopathologic Parameters |
Number |
TLR4 expression levels |
P-Value |
|
|
|
||||
|
Low |
High |
|||
|
|
||||
|
Age (years) |
||||
|
≤60 |
83 |
36 |
47 |
0.134 |
|
>60 |
23 |
6 |
17 |
|
|
Gender |
||||
|
Male |
88 |
36 |
52 |
0.546 |
|
Female |
18 |
6 |
12 |
|
|
Cirrhosis |
||||
|
Absence |
42 |
17 |
35 |
0.018* |
|
Presence |
64 |
35 |
29 |
|
|
AFP (ng/mL) |
||||
|
≤20 |
24 |
11 |
13 |
0.479 |
|
>20 |
82 |
31 |
51 |
|
|
HBsAg |
||||
|
Negative |
15 |
7 |
9 |
0.714 |
|
Positive |
90 |
35 |
55 |
|
|
Tumor size (cm) |
||||
|
≤5 |
35 |
19 |
16 |
0.030* |
|
>5 |
71 |
23 |
48 |
|
|
Tumor margin |
||||
|
Clear |
34 |
19 |
15 |
0.019* |
|
Invovled |
72 |
23 |
49 |
|
|
Satellite lesion |
||||
|
Absence |
77 |
32 |
45 |
0.507 |
|
Presence |
29 |
10 |
19 |
|
|
Vascular invasion |
||||
|
Absence |
23 |
14 |
9 |
0.019* |
|
Presence |
83 |
28 |
55 |
|
|
Portal vein thrombosis |
||||
|
Absence |
74 |
35 |
39 |
0.014* |
|
Presence |
32 |
7 |
25 |
|
|
UICC T stage |
||||
|
T1 |
16 |
13 |
3 |
<0.001* |
|
T2 |
60 |
26 |
34 |
|
|
T3 |
30 |
3 |
27 |
|
|
|
||||
|
(*P <0.05) |
||||
|
Jing et al. BMC Medicine 2012 10:98 doi:10.1186/1741-7015-10-98 |
||||